Results 51 to 60 of about 2,686,489 (205)

Transcranial Direct Current Stimulation Enhances Cognitive Function in Patients with Mild Cognitive Impairment and Early/Mid Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Brain Sciences, 2022
Transcranial direct current stimulation (tDCS) i a non-invasive brain stimulation which is considered to have the potential to improve cognitive impairment in patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD).
Jiajie Chen, Zheng Wang, Qin Chen, Yu Fu, Kai Zheng   +4 more
doaj   +1 more source

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 2005
Mild cognitive impairment (MCI) has been considered a transitional state between normal aging and dementia, characterised by memory impairment but normal general cognitive functioning. Recently other cognitive deficits have been reported. This has led to a modification of MCI criteria.To examine which neuropsychological tests most clearly distinguish ...
A, Nordlund, S, Rolstad, P, Hellström, M, Sjögren, S, Hansen, A, Wallin   +5 more
openaire   +2 more sources

Valid olfactory impairment tests can help identify mild cognitive impairment: an updated meta-analysis

Frontiers in Aging Neuroscience
BackgroundOlfactory testing is emerging as a potentially effective screening method for identifying mild cognitive impairment in the elderly population.ObjectiveOlfactory impairment is comorbid with mild cognitive impairment (MCI) in older adults but is ...
Chunyi Zhou, Chongming Yang, Yating Ai, Xueling Fang, Ailin Zhang, Yuncui Wang, Yuncui Wang, Yuncui Wang, Hui Hu, Hui Hu, Hui Hu   +10 more
doaj   +1 more source

Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients’ Blood

Biomedicines, 2023
Mild cognitive impairment (MCI) is a transitional clinical stage prior to dementia. Patients with amnestic MCI have a high risk of progression toward Alzheimer’s disease.
Bruna De Felice, Cinzia Coppola, Simona Bonavita, Elisabetta Signoriello, Concetta Montanino, Federica Farinella   +5 more
doaj   +1 more source

For debate: substituting placebo controls in long-term Alzheimer's prevention trials [PDF]

, 2011
INTRODUCTION: Novel compounds with potential to attenuate or stop the progression of Alzheimer's disease (AD) from its presymptomatic stage to dementia are being tested in man.
null null, Manfred Berres, René Spiegel, André R Miserez, Berres, Manfred, Miserez, André R., Alzheimer's Disease Neuroimaging Initiative,, Andreas U Monsch, Spiegel, René, Monsch, Andreas U.   +9 more
core   +1 more source

Exploration of demographic prevalence of mild cognitive impairment using Montreal cognitive assessment: A cross-sectional pilot study in the Cape Coast Metropolis, Ghana.

IBRO Neuroscience Reports
Background: The Global prevalence of dementia is projected to rise, particularly in low and middle-income countries like Ghana. Mild cognitive impairment (MCI), an intermediate phase between normal cognitive aging and dementia, is characterized by an ...
David Larbi Simpong, George Nkrumah Osei, Richeal Odarko Mills, Christopher Amaleyele Anyebem, Benjamin Kofi Aikins, Charlotte Gyanwaa Melfah, Bridget Amoanimaa Osei, Ansumana Bockarie   +7 more
doaj   +1 more source

Psychological well-being in individuals with mild cognitive impairment

, 2014
Objectives: Cognitive impairments associated with aging and dementia are major sources of burden, deterioration in life quality, and reduced psychological well-being (PWB).
Valenzuela, M ; https://orcid.org/, Sachdev ; https://orcid.org/, Fiatarone Singh, M, Gates, N ; https://orcid.org/   +3 more
core   +2 more sources

Trait Impulsivity Is Independent of Mild Cognitive Impairment in a Parkinson’s Disease Cohort

Parkinson's Disease, 2019
Introduction. Patients with Parkinson’s disease (PD) commonly experience cognitive deficits and some also develop impulse control disorders (ICDs); however, the relationship between impulsivity and cognitive dysfunction remains unclear.
Ashani Jeyadevan, Megan C. Bakeberg, Michelle Byrnes, Jade Kenna, Soumya Ghosh, Rick Stell, Sue Walters, Tess Evans, Sarah McGregor, Malcolm Horne, Frank L. Mastaglia, Ryan S. Anderton   +11 more
doaj   +1 more source

Disease progression and costs at the 3‐year follow‐up of the GERAS‐US study

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023
Introduction GERAS‐US prospectively characterized clinical and economic outcomes of early symptomatic Alzheimer's disease (AD). Societal cost changes were examined in amyloid‐positive patients with mild cognitive impairment due to AD (MCI) and mild ...
Julie M. Chandler, Dorene M. Rentz, Anthony Zagar, Yongin Kim, Ronald L. Schwartz, Howard Fillit   +5 more
doaj   +1 more source

Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease

Frontiers in Aging Neuroscience, 2023
ObjectivesOlfactory disorder is one of the sensory features that reflects a decline in cognitive function. However, olfactory changes and the discernibility of smell testing in the aging population have yet to be fully elucidated.
Yan Mi, Yan Mi, Xiaojuan Ma, Xiaojuan Ma, Shan Du, Shan Du, Chengxue Du, Chengxue Du, Xiaobo Li, Xiaobo Li, Huihui Tan, Huihui Tan, Jie Zhang, Jie Zhang, Qi Zhang, Qi Zhang, Wenzhen Shi, Wenzhen Shi, Gejuan Zhang, Gejuan Zhang, Ye Tian, Ye Tian   +21 more
doaj   +1 more source